Ketorolac Tromethamine
Market
Ketorolac Tromethamine API Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Ketorolac Tromethamine API Market Size and Growth
The Ketorolac Tromethamine API market exhibits significant growth potential due to rising demand for analgesics and anti-inflammatory medications. The market size is estimated to reach approximately $500 million by 2025, driven by increasing surgical procedures and chronic pain management. Competitive landscape includes both established players and emerging manufacturers.
Companies Covered
(Covid 19 Impact Covered)
◍ Dr. Reddy’s Laboratories Ltd.
◍ Farmak A.S
◍ UQUIFA
◍ Symed Labs Limited
◍ Vasudha Pharma Chem Limited
◍ Recordati
◍ Smilax Laboratories Limited
◍ Nishchem International Pvt. Ltd.
◍ Chromo Laboratories India Pvt Ltd
◍ Renanpharma
The Ketorolac Tromethamine API market features key players like Dr. Reddy’s Laboratories, Farmak A.S, and Symed Labs, focusing on high-quality production and innovation. These companies enhance market growth through strategic partnerships, advanced manufacturing processes, and expanding distribution channels. Sales figures for select companies include:
- Dr. Reddy’s Laboratories: ~$2.2 billion
- Recordati: ~$1.5 billion
- Farmak A.S: ~€150 million.
◍ Zhejiang Charioteer Pharmaceutical Co.,Ltd
Request Sample Report
Market Segmentation
By Application
◍ Ketorolac Tromethamine Capsules
◍ Ketorolac Tromethamine Tablets
◍ Ketorolac Tromethamine Injection
◍ Others
By Product
◍ Purity≥98%
◍ Purity<98%
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
